[{"arm_notes": "", "treatment_id": null, "treatment_name": "Adult group: Vaccine versus placebo group:0; 21; 42 days immunity;Elder group: Vaccine versus placebo:0; 21; 42 days immunity;Immunogenic subgroup group: Vaccine versus placebo:0; 21; 42 days immunity;", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Adult group: Vaccine versus placebo group:0; 21; 42 days immunity", "treatment_type": "Placebo", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Elder group: Vaccine versus placebo:0; 21; 42 days immunity", "treatment_type": "Placebo", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Immunogenic subgroup group: Vaccine versus placebo:0; 21; 42 days immunity;", "treatment_type": "Placebo", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "3;Days0-21-42;Adult group", "treatment_id": 1089, "treatment_name": "Recombinant sars-cov-2 vaccine (sf9 cell)", "treatment_type": "Protein subunit", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "3;Days0-21-42;Elder group", "treatment_id": 1089, "treatment_name": "Recombinant sars-cov-2 vaccine (sf9 cell)", "treatment_type": "Protein subunit", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "3;Days0-21-42;Immunogenic group", "treatment_id": 1089, "treatment_name": "Recombinant sars-cov-2 vaccine (sf9 cell)", "treatment_type": "Protein subunit", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "3;Days0-21-42;Immunogenic group", "treatment_id": 1089, "treatment_name": "Recombinant sars-cov-2 vaccine (sf9 cell)", "treatment_type": "Protein subunit", "pharmacological_treatment": "Vaccine"}]